Jillian Gottlieb
Overview
Explore the profile of Jillian Gottlieb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients
Ghermezi M, Li M, Vardanyan S, Harutyunyan N, Gottlieb J, Berenson A, et al.
Haematologica
. 2016 Dec;
102(4):785-795.
PMID: 28034989
B-cell maturation antigen is expressed on plasma cells. In this study, we have identified serum B-cell maturation antigen as a novel biomarker that can monitor and predict outcomes for multiple...
2.
Berenson A, Vardanyan S, David M, Wang J, Harutyunyan N, Gottlieb J, et al.
Ann Hematol
. 2016 Dec;
96(3):449-459.
PMID: 27933373
New classes of drugs including the proteasome inhibitors (PI) bortezomib and, more recently, carfilzomib and the immunomodulatory agent lenalidomide have shown improved outcomes for multiple myeloma (MM) patients during the...
3.
Berenson A, Vardanyan S, David M, Wang J, Harutyunyan N, Gottlieb J, et al.
Ann Hematol
. 2016 Dec;
96(3):441-448.
PMID: 27913860
Despite recent advances made in its treatment, multiple myeloma (MM) remains an incurable B cell malignancy. Thus, the objective for treating these patients is to prolong overall survival (OS) and...
4.
Harutyunyan N, Vardanyan S, Ghermezi M, Gottlieb J, Berenson A, Andreu-Vieyra C, et al.
Br J Haematol
. 2016 Mar;
174(1):81-7.
PMID: 27017948
Multiple myeloma (MM) is characterized by the enhanced production of the same monoclonal immunoglobulin (M-Ig or M protein). Techniques such as serum protein electrophoresis and nephelometry are routinely used to...
5.
Sanchez E, Gillespie A, Tang G, Ferros M, Harutyunyan N, Vardanyan S, et al.
Clin Cancer Res
. 2016 Mar;
22(13):3383-97.
PMID: 26960399
Purpose: Reduced uninvolved immunoglobulin (Ig) levels are a hallmark of multiple myeloma. We previously showed that B-cell maturation antigen (BCMA) is solubilized and at high levels in multiple myeloma patient...
6.
Krieger N, Gruskin S, Singh N, Kiang M, Chen J, Waterman P, et al.
Am J Public Health
. 2015 Feb;
105(4):680-2.
PMID: 25713932
US infant death rates for 1960 to 1980 declined most quickly in (1) 1970 to 1973 in states that legalized abortion in 1970, especially for infants in the lowest 3...